
Study of cell exhaustion in immunotherapy-resistant tumors could significantly improve the benefits of cancer immunotherapy for patients with treatment resistant types of cancer.
Erin Hunter is an assistant editor at Pharmacy Times®. She is a proud alumna of the University of Massachusetts. She graduated with degrees in Journalism, Art History, and Environmental Conservation.
Study of cell exhaustion in immunotherapy-resistant tumors could significantly improve the benefits of cancer immunotherapy for patients with treatment resistant types of cancer.
With or without US federal regulation, CBD companies should provide consumers with more transparent information about their products.
Findings may offer insight into new strategies to tackle skin cancer in patients already treated with a prior line of therapy.
Alpelisib plus the antioxidant N-acetylcysteine sensitizes NF1 knockout cells to PI3Kα inhibition and reverts their glycolytic phenotype in patients with advanced forms of breast cancer.
The study will be conducted in Brazil, where PrEP use for HIV continues to be lower than desired.
The novel antibody-drug conjugate is the first to demonstrate overall survival benefits in patients who were already treated with therapy.
The 2022-2023 COVID-19 season did not have a significant surge of COVID-19 like it did early on in the COVID-19 pandemic.
The study shed light on the importance of the source of vaccine information and other factors that prevent lifesaving vaccination.
Data from the expanded trial suggests that the NVX-CoV2373 COVID-19 vaccine protects against multiple viral variants.
It is possible that the pandemic had a positive impact on influenza vaccination rates.
At least 58% of mice treated with combined CRISPR therapies showed signs of complete HIV-1 viral elimination.
The therapy had a clinically meaningful response in patients with relapsed or refractory (R/R) follicular lymphoma and R/R mantle cell lymphoma.
Clearer skin on the face and hands lasted 1 year into treatment.
More than half of patients with Alzheimer disease administered donanemab showed a significantly reduced cognitive and functional decline.
Study examines association between breast cancer survival and neighborhood-level measures such as socioeconomic status.
Study sheds light on the importance of the source of vaccine information and other factors that prevent lifesaving influenza or pneumococcal vaccination.
Misinformation on YouTube promotes women wiping front to back as a non-evidence-based hygiene practice to prevent urinary tract infection.
Mendelian randomization makes it possible to infer if a drug target protein will have an on-target effect on disease-relevant traits.
A combination of cognitive behavioral therapy and medication had the most profound and stable result for patients suffering from insomnia.
Neutralizing monoclonal antibody therapies found to improve outcomes for unvaccinated and nonhospital patients at high risk of poor outcome for SARS-CoV-2.
Study shows eplontersen maintains a consistent and sustained treatment effect and reinforces its potential treating hereditary transthyretin-mediated amyloid polyneuropathy, which can lead to heart failure.
Immature data suggest enzalutamide combination improves overall survival in patients with high-risk biochemical recurrence.
The system is considered effective at identifying residual breast cancer following surgical resection.
The treatment showed significant improvement in patients in patients who require frequent blood transfusions and are at risk of infection.
Cephalosporin treatment is a risk factor of Clostridioides difficile infection.
Screening tools are becoming widely used to help clinicians address the needs of patients with diabetes to improve health outcomes.
Relative risk of cancer-related death differed according to age of diagnosis.
Nearly 18-times more patients on trizepatide 15 mg achieved a body weight reduction of 15% or more compared to placebo.
The BCG vaccine was more likely to cause symptomatic or severe COVID-19 in patients that had a preexisting condition, such as heart disease, by 6 months.
Study shows intramuscular injection may improve treatment success by increasing the speed of drug absorption.